CIK 0001388320
- Non-accelerated filer
- Smaller reporting company
Actinium Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ATNM
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 880378336
- Phone
- +1 646-677-3870
- Business address
- 100 PARK AVE., 23RD FLOOR, NEW YORK, NY, 10017
- Former names
- Cactus Ventures, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-02 | SETH SANDESH Chief Executive Officer | Grant or award | +753,600 | 938,081 | ||
| 2026-09-02 | SETH SANDESH Chief Executive Officer | Grant or award | +1,027,274 | 1,965,355 | ||
| 2026-09-02 | SETH SANDESH Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +1,130,400 | 1,130,400 | ||
| 2025-08-18 | SETH SANDESH Chief Executive Officer | Shares withheld for taxes | −120,900 | $1.71 | $207K | 184,481 |
| 2025-03-31 | SETH SANDESH Chief Executive Officer | Returned to the company · Stock Option (Right to Buy) | −16,666 | 0 | ||
| 2025-03-31 | SETH SANDESH Chief Executive Officer | Returned to the company · Stock Option (Right to Buy) | −25,000 | 0 | ||
| 2025-03-31 | SETH SANDESH Chief Executive Officer | Returned to the company · Stock Option (Right to Buy) | −33,333 | 0 | ||
| 2025-03-31 | SETH SANDESH Chief Executive Officer | Returned to the company · Stock Option (Right to Buy) | −50,000 | 0 | ||
| 2025-03-31 | SETH SANDESH Chief Executive Officer | Returned to the company · Stock Option (Right to Buy) | −139,062 | 0 | ||
| 2025-03-31 | SETH SANDESH Chief Executive Officer | Returned to the company · Stock Option (Right to Buy) | −310,182 | 0 | ||
| 2025-03-31 | SETH SANDESH Chief Executive Officer | Returned to the company · Stock Option (Right to Buy) | −827,366 | 0 | ||
| 2025-03-31 | SETH SANDESH Chief Executive Officer | Returned to the company · Stock Option (Right to Buy) | −984,367 | 0 | ||
| 2023-12-28 | SETH SANDESH Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +984,367 | 984,367 | ||
| 2022-08-17 | SETH SANDESH Chief Executive Officer | Grant or award | +300,000 | 305,381 | ||
| 2022-07-01 | SETH SANDESH Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +827,366 | 827,366 | ||
| 2021-09-01 | SETH SANDESH Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +310,182 | 310,182 | ||
| 2020-08-12 | SETH SANDESH Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +139,062 | 139,062 | ||
| 2019-07-12 | SETH SANDESH CEO | Grant or award · Options to purchase common stock | +1,500,000 | $0.23 | $348K | 1,500,000 |
| 2019-02-21 | SETH SANDESH Chairman & CEO | Option exercise | +8,125 | $0.60 | $5K | 161,458 |
| 2018-12-10 | SETH SANDESH Chairman & CEO | Purchase | +10,000 | $0.44 | $4K | 153,333 |
Page 1 of 3 · 46 trades